Skip to main content
TipRanks
Go Ultimate75% OFF

Keros Therapeutics (KROS) Balance Sheet

371 Followers

Keros Therapeutics Balance Sheet

Keros Therapeutics's total assets for Q3 2026 were $307.37M, an increase of 6.87% from the previous quarter. KROS total liabilities were $28.27M for the fiscal quarter, a 11.84% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 338.02M$ 615.89M$ 370.02M$ 306.78M$ 255.25M
$ 34.89M$ 44.33M$ 37.81M$ 29.36M$ 12.08M
$ 303.13M$ 571.55M$ 332.21M$ 277.42M$ 243.17M

Currency in USD

Keros Therapeutics Liabilities to Assets

0250M500M750M0 %40 %80 %120 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets